Giripladib

Overview

Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A 2 (cPLA 2 ) . Giripladib can be used for osteoarthritis and breast cancer research.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phospholipase

Product Information

• Catalog No.: HY-14952
• CAS No.: 865200-20-0
• Molecular Formula: C41H36ClF3N2O4S
• Molecular Weight: 745.25
• Purity: 99.68%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source